Cure Today1d
How Subcutaneous vs IV May Affect Treatment Adherence in Cancer Care
Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version ...
Medical News Today2d
Could intermittent fasting earlier in the day help reduce more abdominal fat?
Following an "early" time-restricted intermittent fasting pattern is more beneficial for improved blood sugar regulation, and ...
GlobalData on MSN12d
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...
Cure Today5d
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...
Healio1d
Novel obesity drug induces up to 22% weight loss with no safety concerns
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...
TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst
TG Therapeutics expects to report initial data on the subcutaneous form of Briumvi in early 2025. Click here to read why TGTX ...
HealthDay on MSN2d
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib
Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than ...